Clinical Trials Browser

Phase 1/2 × Glioma × ribociclib × Clear all

NCT02607124 2020-11-05

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

Phase 1/2 Terminated

11 enrolled 10 charts

Diffuse Intrinsic Pontine Glioma, Glioma